Authors: Bellec, Stéphanie¹; Hémon, Denis²; Clavel, Jacqueline³

Source: European Journal of Epidemiology, Volume 20, Number 8, August 2005 , pp. 663-671(9)

Publisher: Springer

Abstract:

Cluster investigations remain an important public health issue as the number of reported clusters and public concern increase. This study shows how statistical considerations and a simulation tool may be helpful in providing communities with proper answers to the questions usually raised in such situations: How surprising is an observed childhood cancer excess? What could be learned from a statistical test? What could be learned from a case–control study? Using real demographic and incidence-rate data together with simulations based on the hypothesis that incidence rates are homogeneous, the probabilities of observing given situations were estimated. A number of real situations have been used as examples. The results of the simulation study showed, in detail, that no reliable information on the reality of an observed excess could be obtained a posteriori from a statistical test. A cluster of the same size may or may not be surprising, depending on the spatial area and time window to which the cases are related (i.e., the expected number of cases), and depending on the size of the referential territory to which this area is associated. The lack of power of a case–control study if no particular unusual exposure is present is also addressed. The approach described in this paper can easily be reproduced and adapted to many situations. It may be of assistance to health departments conducting cluster investigations and communicating with the public.

Keywords: Public health; Cluster investigation; Childhood cancer

Document Type: Research article

DOI: http://dx.doi.org/10.1007/s10654-005-7924-x

Affiliations: 1: French Institute of Health and Medical Research, INSERM, U170, IFR69, Université Paris XI, 16, av. Paul Vaillant-Couturier, F-94807, cedex, Villejuif, France, Email: bellec@vjf.inserm.fr 2: National French Registry of Childhood Leukemia and Lymphoma, U170, IFR69, INSERM, Université Paris XI, Villejuif, France, 3: French Institute of Health and Medical Research, INSERM, U170, IFR69, Université Paris XI, 16, av. Paul Vaillant-Couturier, F-94807, cedex, Villejuif, France,

Publication date: 2005-08-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Public Health
• By this author: Bellec, Stéphanie ;  Hémon, Denis ;  Clavel, Jacqueline

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers